Stryker (SYK) Total Current Liabilities (2009 - 2026)
Stryker's (SYK) quarterly Total Current Liabilities came in at $6.7 billion in Q2 2026, down 8.29% year-over-year from $7.3 billion in Q2 2025, and up 5.84% quarter-over-quarter from $6.3 billion in Q1 2026.
Analysis
Stryker (SYK) Total Current Liabilities (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Total Current Liabilities for 18 consecutive years, with $6.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 8.29% year-over-year to $6.7 billion in Q2 2026; TTM through Jun 2026 was $6.7 billion, a 8.29% decrease from a year earlier, with the FY2025 full-year figure at $7.8 billion, up 2.34% from the prior year.
- Total Current Liabilities was $6.7 billion for Q2 2026 at Stryker, up from $6.3 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $7.9 billion in Q1 2025 and troughed at $4.4 billion in Q2 2022.
- A 5-year average of $6.7 billion and a median of $6.9 billion in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 63.16% in 2023 and declined 20.36% in 2026, its largest moves.
- Over 5 years, Total Current Liabilities stood at $6.3 billion in 2022, then grew by 25.67% to $7.9 billion in 2023, then decreased by 3.85% to $7.6 billion in 2024, then gained by 2.34% to $7.8 billion in 2025, then dropped by 14.24% to $6.7 billion in 2026.
- The last three Total Current Liabilities figures came in at $6.7 billion (Q2 2026), $6.3 billion (Q1 2026), and $7.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 178.19 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 124.42 Bn | 119.20 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 118.24 Bn | 109.42 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 105.02 Bn | 101.55 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 66.48 Bn | 65.94 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.34 Bn | 30.40 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 18.16 Bn | 17.75 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.68 Bn |
| Mar 31, 2026 | 6.32 Bn |
| Dec 31, 2025 | 7.79 Bn |
| Sep 30, 2025 | 7.41 Bn |
| Jun 30, 2025 | 7.29 Bn |
| Mar 31, 2025 | 7.93 Bn |
| Dec 31, 2024 | 7.62 Bn |
| Sep 30, 2024 | 7.67 Bn |
| Jun 30, 2024 | 6.93 Bn |
| Mar 31, 2024 | 6.96 Bn |
| Dec 31, 2023 | 7.92 Bn |
| Sep 30, 2023 | 7.46 Bn |
| Jun 30, 2023 | 6.58 Bn |
| Mar 31, 2023 | 5.87 Bn |
| Dec 31, 2022 | 6.30 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.40 Bn |
| Mar 31, 2022 | 4.41 Bn |
| Dec 31, 2021 | 4.55 Bn |
| Sep 30, 2021 | 4.45 Bn |